|
|
|
|
|
|
Sponsors and Collaborators: |
Asociación para Evitar la Ceguera en México Instituto Nacional de Referencia Epidemiológica (INdRE) |
Information provided by: | Asociación para Evitar la Ceguera en México |
ClinicalTrials.gov Identifier: | NCT00600236 |
One of the first causes of irreversible blindness in mexican population is diabetic retinopathy which is clearly diferent between patients the time of evolution and development of retinopathy and complications. The aim of this study is to explore the inmunogenetic profile and the influence of HLA in this variations of the sickness to predict the severity of diabetic complications.
Condition | Intervention | Phase |
Diabetes Mellitus Type 2 Proliferative Diabetic Retinopathy |
Procedure: blood sample |
Phase III |
MedlinePlus related topics: | Diabetes Diabetic Eye Problems Retinal Disorders |
Study Type: | Interventional |
Study Design: | Prevention, Non-Randomized, Single Blind, Active Control, Parallel Assignment, Efficacy Study |
Official Title: | HLA and it Relation With the Development of Proliferative Diabetic Retinopathy in Mexican Population |
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Mexico, Mexico DF | |||||
Asociación para Evitar la Ceguera en México, Hospital "Luis Sanchez Bulnes" | |||||
Mexico City, Mexico DF, Mexico, 04030 |
Asociación para Evitar la Ceguera en México |
Instituto Nacional de Referencia Epidemiológica (INdRE) |
Principal Investigator: | Hugo Quiroz-Mercado, MD | Asociación para Evitar la Ceguera en México, Hospital "Luis Sánchez Bulnes" |
Study ID Numbers: | APEC-0018 |
First Received: | June 30, 2006 |
Last Updated: | January 23, 2008 |
ClinicalTrials.gov Identifier: | NCT00600236 |
Health Authority: | Mexico: Secretaria de Salud |
|
|
|
|